Title: To analyse the efficacy and safety of valsartan along with combination of valsartan and hydrochlorothiazide in mild to moderate arterial hypertension patients
Authors: Dr N. Suresh, Dr V. Paramasivam
DOI: https://dx.doi.org/10.18535/jmscr/v7i8.144
Abstract
Background and Aim: The aim of the study was to analyse the effect of valsartan and combination of valsartan and hydrochlorothiazide (HCTZ) in mild to moderate arterial hypertension patients.
Methods: A study sample of 200 patients were taken which included 100 patients of Mild hypertension and 100 patients of Moderate hypertension. The patients were assessed for a total of 16 weeks. Depending upon the peripheral blood pressure readings, the dosage of valsartan and combination of valsartan and HCTZ was administered.
Results: It was observed that valsartan and combination of valsartan and HCTZ efficaciously reduced the blood pressure in mild to moderate arterial hypertension patients.
Conclusions: Valsartan and combination of valsartan/HCTZ are very effective drugs to reduce the blood pressure.
Keywords: Valsartan, Hydrochlorothiazide, arterial hypertension.
References
- Accetto R, Jr JW, Vincelj J, Sirenko Y, Yevgenyevna IC, Zagar BB. The efficacy and safety of valsartan and a combination of valsartan and hydrochlorothiazide in the treatment of patients with mild to moderate arterial hypertension: a subgroup analysis of the effect of valsartan and its combination with hydrochlorothiazide on pulse wave velocity and central blood pressure. Kardiologia Polska 2018; 76, 2: 328–37.
- Siddiqui N, Husain A, Chaudhry L, Alam MS, Mitra M, Bhasin PS. Pharmacological and Pharmaceutical Profile of Valsartan: A Review. Journal of Applied Pharma-ceutical Science 01 (04); 2011: 12-19
- Asmar RG, London GM, O’Rourke ME, et al. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol. Hypertension. 2001; 38(4): 922–926.
- Accetto R, Chazova IY, Sirenko Y, et al. The efficacy and safety of valsartan and combination of valsartan and hydrochlorothiazide in the treatment of patients with mild to moderate arterial hypertension - the VICTORY trial. Kardiol Pol. 2017; 75(1): 55–64.
- Singh S, Shankar R, Singh GP. Prevalence and associated risk factors of hypertension: A cross sectional study in urban varanasi. Int J Hypertens. 2017; 2017: 5491838.
- Mansour M, Nozha A, Khalil M. Recent advances in the management of hypertension. Saudi medical journal 29(8):1083-7.